BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7518348)

  • 1. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.
    Alcaraz A; Takahashi S; Brown JA; Herath JF; Bergstralh EJ; Larson-Keller JJ; Lieber MM; Jenkins RB
    Cancer Res; 1994 Aug; 54(15):3998-4002. PubMed ID: 7518348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.
    Takahashi S; Alcaraz A; Brown JA; Borell TJ; Herath JF; Bergstralh EJ; Lieber MM; Jenkins RB
    Clin Cancer Res; 1996 Jan; 2(1):137-45. PubMed ID: 9816100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
    Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
    Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
    Takahashi S; Qian J; Brown JA; Alcaraz A; Bostwick DG; Lieber MM; Jenkins RB
    Cancer Res; 1994 Jul; 54(13):3574-9. PubMed ID: 8012984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
    Gburek BM; Kollmorgen TA; Qian J; D'Souza-Gburek SM; Lieber MM; Jenkins RB
    J Urol; 1997 Jan; 157(1):223-7. PubMed ID: 8976257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
    Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi OP
    Am J Pathol; 1994 Sep; 145(3):624-30. PubMed ID: 8080044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aneuploidy of chromosome Y in prostate tumors and seminal vesicles: a possible sign of aging rather than an indicator of carcinogenesis?
    Nadal M; Pera G; Pujadas J; Abril J; González L; Aguiló F; Condom E; Gómez-Zaera M; Nunes V
    Mol Carcinog; 2007 Jul; 46(7):543-52. PubMed ID: 17295237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic profiles as additional markers to pathological features in clinically localized prostate carcinoma.
    Gallucci M; Merola R; Farsetti A; Orlandi G; Sentinelli S; De Carli P; Leonardo C; Carlini P; Guadagni F; Sperduti I; Cianciulli AM
    Cancer Lett; 2006 Jun; 237(1):76-82. PubMed ID: 16002207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trisomy 7 by dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression.
    Wang RY; Troncoso P; Palmer JL; El-Naggar AK; Liang JC
    Clin Cancer Res; 1996 Sep; 2(9):1553-8. PubMed ID: 9816332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.
    Mendelin J; Grayson M; Wallis T; Visscher DW
    Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
    Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
    Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
    Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H
    Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Urology; 1995 Dec; 46(6):837-42. PubMed ID: 7502426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
    Kapranos N; Kounelis S; Karantasis H; Kouri E
    Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.